Seventure Partners
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Canada, Germany, France, Italy, Denmark, Switzerland, Spain, Luxembourg, Austria, Netherlands, Portugal, Sweden, Belgium, Israel, Norway, Finland, Poland, Czech Republic
Industries Focus
- Technology
- Healthcare
- Software
- FoodTech
- FinTech
- SaaS
- Aquaculture
- Digital Health
- Cybersecurity
- Biotechnology
- Blue Economy
- RetailTech
- Nutrition
- Animal & Agriculture
- Sport & Wellness
Investment Size:
500,000 to 20,000,000 USD
Investor Details Founded: 1997
Seventure Partners is a prominent European venture capital firm specializing in financing innovative companies with high growth potential in the digital technology and life sciences sectors. Established in 1997, the firm has invested in over 250 companies, managing assets totaling approximately €854 million as of June 30, 2025. Seventure Partners is deeply involved in fostering economic growth and technological advancement, particularly in France and Europe.
The firm's investment strategy focuses on two main areas: digital technologies and life sciences. In digital technologies, Seventure Partners invests in sectors such as fintech, retailtech, and cybersecurity, primarily in Western Europe. In life sciences, the firm targets areas including biotechnology, digital health, nutrition, foodtech, blue economy, aquaculture, animal & agriculture, and sport & wellness, with a particular emphasis on microbiome-related innovations across Europe, Israel, Asia, and North America.
Seventure Partners supports companies from early-stage investments through to later stages, including growth and pre-IPO phases. The firm deploys capital ranging from €500,000 to €10 million per funding round, with total investments up to €20 million per company. This approach has enabled Seventure Partners to build a diverse portfolio of innovative companies across various sectors and stages of development.
Requirements
- Innovative business models
- High growth potential
- Alignment with Seventure Partners' focus areas
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- CorWave
- Kayentis
- Domain Therapeutics
- PEP-Therapy
- Animab
Mentioned In
-
$19.95
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$9.95
-
$14.95
-
$19.95
-
$99.00
Claim this Investor
Are you an official representative of Seventure Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim